Erythrocytes in multiple sclerosis: forgotten contributors to the pathophysiology?

Kira Groen, Vicki E. Maltby, Katherine Sanders, Rodney J. Scott, Lotti Tajouri, Jeannette Lechner-Scott

Research output: Contribution to journalArticleResearchpeer-review

92 Downloads (Pure)

Abstract

Multiple sclerosis (MS) is an autoimmune disease characterised by lymphocytic infiltration of the central nervous system and subsequent destruction of myelin and axons. On the background of a genetic predisposition to autoimmunity, environmental triggers are assumed to initiate the disease. The majority of MS research has focused on the pathological involvement of lymphocytes and other immune cells, yet a paucity of attention has been given to erythrocytes, which may play an important role in MS pathology. The following review briefly summarises how erythrocytes may contribute to MS pathology through impaired antioxidant capacity and altered haemorheological features. The effect of disease-modifying therapies on erythrocytes is also reviewed. It may be important to further investigate erythrocytes in MS, as this could broaden the understanding of the pathological mechanisms of the disease, as well as potentially lead to the discovery of novel and innovative targets for future therapies.
Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalMultiple Sclerosis
Volume2
DOIs
Publication statusPublished - 2016

Fingerprint

Multiple Sclerosis
Erythrocytes
Pathology
Genetic Predisposition to Disease
Myelin Sheath
Autoimmunity
Autoimmune Diseases
Axons
Central Nervous System
Antioxidants
Lymphocytes
Therapeutics
Research

Cite this

Groen, Kira ; Maltby, Vicki E. ; Sanders, Katherine ; Scott, Rodney J. ; Tajouri, Lotti ; Lechner-Scott, Jeannette. / Erythrocytes in multiple sclerosis: forgotten contributors to the pathophysiology?. In: Multiple Sclerosis. 2016 ; Vol. 2. pp. 1-9.
@article{e17b0e1ab8a7437ca0322809931c164f,
title = "Erythrocytes in multiple sclerosis: forgotten contributors to the pathophysiology?",
abstract = "Multiple sclerosis (MS) is an autoimmune disease characterised by lymphocytic infiltration of the central nervous system and subsequent destruction of myelin and axons. On the background of a genetic predisposition to autoimmunity, environmental triggers are assumed to initiate the disease. The majority of MS research has focused on the pathological involvement of lymphocytes and other immune cells, yet a paucity of attention has been given to erythrocytes, which may play an important role in MS pathology. The following review briefly summarises how erythrocytes may contribute to MS pathology through impaired antioxidant capacity and altered haemorheological features. The effect of disease-modifying therapies on erythrocytes is also reviewed. It may be important to further investigate erythrocytes in MS, as this could broaden the understanding of the pathological mechanisms of the disease, as well as potentially lead to the discovery of novel and innovative targets for future therapies.",
author = "Kira Groen and Maltby, {Vicki E.} and Katherine Sanders and Scott, {Rodney J.} and Lotti Tajouri and Jeannette Lechner-Scott",
year = "2016",
doi = "10.1177/2055217316649981",
language = "English",
volume = "2",
pages = "1--9",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "Sage Publications India Pvt. Ltd",

}

Erythrocytes in multiple sclerosis: forgotten contributors to the pathophysiology? / Groen, Kira; Maltby, Vicki E.; Sanders, Katherine; Scott, Rodney J.; Tajouri, Lotti; Lechner-Scott, Jeannette.

In: Multiple Sclerosis, Vol. 2, 2016, p. 1-9.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Erythrocytes in multiple sclerosis: forgotten contributors to the pathophysiology?

AU - Groen, Kira

AU - Maltby, Vicki E.

AU - Sanders, Katherine

AU - Scott, Rodney J.

AU - Tajouri, Lotti

AU - Lechner-Scott, Jeannette

PY - 2016

Y1 - 2016

N2 - Multiple sclerosis (MS) is an autoimmune disease characterised by lymphocytic infiltration of the central nervous system and subsequent destruction of myelin and axons. On the background of a genetic predisposition to autoimmunity, environmental triggers are assumed to initiate the disease. The majority of MS research has focused on the pathological involvement of lymphocytes and other immune cells, yet a paucity of attention has been given to erythrocytes, which may play an important role in MS pathology. The following review briefly summarises how erythrocytes may contribute to MS pathology through impaired antioxidant capacity and altered haemorheological features. The effect of disease-modifying therapies on erythrocytes is also reviewed. It may be important to further investigate erythrocytes in MS, as this could broaden the understanding of the pathological mechanisms of the disease, as well as potentially lead to the discovery of novel and innovative targets for future therapies.

AB - Multiple sclerosis (MS) is an autoimmune disease characterised by lymphocytic infiltration of the central nervous system and subsequent destruction of myelin and axons. On the background of a genetic predisposition to autoimmunity, environmental triggers are assumed to initiate the disease. The majority of MS research has focused on the pathological involvement of lymphocytes and other immune cells, yet a paucity of attention has been given to erythrocytes, which may play an important role in MS pathology. The following review briefly summarises how erythrocytes may contribute to MS pathology through impaired antioxidant capacity and altered haemorheological features. The effect of disease-modifying therapies on erythrocytes is also reviewed. It may be important to further investigate erythrocytes in MS, as this could broaden the understanding of the pathological mechanisms of the disease, as well as potentially lead to the discovery of novel and innovative targets for future therapies.

U2 - 10.1177/2055217316649981

DO - 10.1177/2055217316649981

M3 - Article

VL - 2

SP - 1

EP - 9

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

ER -